Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions

► Expert panel evaluated published evidence on use of BoNT for urologic disorders. ► We review detrusor sphincter dyssynergia, neurogenic and idiopathic detrusor overactivity, and benign prostatic hyperplasia. ► Data considered for BoNT as a class as well as four individual formulations. ► Clinical recommendations made according to AAN classification scale.